Skip to Main Content

Paper Details

Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases.
Case Reports in Oncology
13
2016
ASPS, Alveolar soft part sarcoma, Metastatic Alveolar Soft Part Sarcoma, Pazopanib, Sunitinib, VEGF, bevacizumab, cediranib, pazopanib, persons, soft tissue sarcoma, sunitinib
Author NameAffiliation
Felicia N WilliamsWinship Cancer Institute, Emory University School of Medicine
  • 1 - 1

Datasets

Release 1.2